Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Endogenous Cannabinoid Signaling

Open access
Piomelli, Daniele, Beltramo, Massimiliano, Giuffrida, Andrea, Stella, Nephi·1998·Neurobiology of Disease

Abstract

There are two principal lines of evidence supporting the existence of an endogenous cannabinoid system. First, it is clear that cannabimimetic drugs exert their effects by binding with high affinity to selective membrane receptors (1–3). Second, substances with cannabimimetic properties, but with chemical structures that greatly differ from those found in plants, have been discovered in animal tissues (4–7). These indications are relevant, but they are open nevertheless to several possible objections. For example, although endogenous cannabimimetic compounds exist, it is conceivable that they may never engage cannabinoid receptors under physiological conditions. Indeed, if these receptors were constitutively active in the absence of agonist, as suggested by studies with heterologous expression models (8), there may be no need for an intrinsic cannabinoid ‘‘system,’’ intended as a group of interconnected cells that produce and respond to endogenous cannabinoids. These and similar concerns highlight the many gaps left unfilled in our understanding of intrinsic cannabinoid modulation. It is now generally agreed that substances with cannabimimetic properties are released during neuronal activity, and that these substances are inactivated by a set of mechanisms parallel to, but distinct from, those utilized for the elimination of established neurotransmitters. But where in brain and peripheral tissues do these reactions take place? And under what circumstances? Are there discrete cannabinergic pathways comparable to, say, dopaminergic ones? Or do endogenous cannabinoids act as local mediators? What behavioral needs regulate endogenous cannabinoid release?And what physiological adaptations are served by such release? To address these questions critically, we need first to recognize certain biochemical and physiological peculiarities of the cannabinoid signaling system which distinguish it from classical neurotransmitters. The nature of these peculiarities is the key theme that will be developed in the present review. ENDOGENOUS CANNABINOIDS

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/nbdi.1998.0221

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 159

Metadata

Authors
Piomelli, D., Beltramo, M., Giuffrida, A., & Stella, N.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
1998-12
Volume
5
Issue
6
Pages
462-473
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2023733270
Cited by
159
References
8
FWCI
6.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endogenous Cannabinoid Signaling. https://app.cochat.ai/papers/10.1006/nbdi.1998.0221
The paper
Piomelli, D., Beltramo, M., Giuffrida, A., & Stella, N. (1998). Endogenous Cannabinoid Signaling. Neurobiology of Disease. https://doi.org/10.1006/nbdi.1998.0221

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.